Physician profile
Hung H Le
NPI 1902913825
$6,622.78
in general payments reported to CMS, 2019-2025
22 companies · $712 in 2025
The $712 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,613 · 2020: $599 · 2021: $820 · 2022: $708 · 2023: $757 · 2024: $414 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,743 · Long Term Medical Supply Or Device Loan: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,742.75 |
| Long Term Medical Supply Or Device Loan | $140.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,592.98 | 2019-2025 | Clareon, Voyager Dslt, Hydrus Microstent |
| Ocular Therapeutix, INC. | $244.32 | 2023 | Dextenza |
| Abbvie INC. | $227.55 | 2022-2025 | |
| Depuy Synthes Sales INC. | $204.96 | 2024-2025 | Trumatch, Matrixmidface |
| Carl Zeiss Meditec USA, INC. | $194.73 | 2023-2025 | Forum, Clarus |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $163.39 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $147.03 | 2019-2023 | |
| Allergan, INC. | $129.66 | 2020-2022 | |
| Optos, INC. | $118.53 | 2019 | |
| Bausch & Lomb Americas INC. | $115.04 | 2023-2025 | Xiidra, Miebo, Envista Envy Iol |
| Glaukos Corporation | $102.45 | 2022-2023 | Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Dompe US, INC. | $77.24 | 2024-2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $70.29 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $59.77 | 2019-2023 | Cequa |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $31.56 | 2025 | Vevye |
| Takeda Pharmaceuticals U.S.A., INC. | $23.16 | 2023 | Trintellix |
| Johnson & Johnson Surgical Vision, INC. | $22.89 | 2021 | |
| Shire North American Group INC | $18.28 | 2019 | |
| Oyster Point Pharma, INC. | $14.94 | 2022 | |
| Thea Pharma INC. | $13.83 | 2023 | |
| Rxsight INC | $11.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hung Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.